Cargando…
Optimal Endpoint of Therapy in IBD: An Update on Factors Determining a Successful Drug Withdrawal
Ulcerative colitis (UC) and Crohn's disease (CD) are chronic inflammatory disorders, which require long term treatment to achieve remission and to prevent relapses and cancer. While current therapies are effective in most cases, they can have rare but serious side effects and are often associat...
Autores principales: | Annaházi, Anita, Molnár, Tamás |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496650/ https://www.ncbi.nlm.nih.gov/pubmed/26199624 http://dx.doi.org/10.1155/2015/832395 |
Ejemplares similares
-
Area of the IBD Disk Correlated Strongly with Disease Activity Compared with the Conventionally Used IBD Disk Score
por: Bacsur, Péter, et al.
Publicado: (2021) -
Relapse rates after withdrawal versus maintaining biologic therapy in IBD patients with prolonged remission
por: Stoker, Annemay M. H., et al.
Publicado: (2023) -
Updating clinical endpoint definitions
por: Hassoun, Paul M., et al.
Publicado: (2013) -
Prognostic Factors of Biologic Therapy in Pediatric IBD
por: Buczyńska, Anna, et al.
Publicado: (2022) -
Biosimilars in Pediatric IBD: Updated Considerations for Disease Management
por: Dipasquale, Valeria, et al.
Publicado: (2022)